National News

We will successfully fight COVID with even greater speed: PM Modi

PM Modi on Saturday reviewed the preparedness of public health response to COVID-19 and the status of supply of Remdesivir and other medicines with Cabinet Secretary, Principal Secretary to PM, Union Home Secretary, Union Health Secretary and Pharma Secretary

PSU Watch Bureau

New Delhi: Prime Minister Narendra Modi chaired a meeting to review the status of preparedness to handle the ongoing Covid-19 pandemic. Various aspects relating to medicines, oxygen, ventilators and vaccination were discussed. PM said that together India had defeated Covid last year & India can do it again, with the same principles but faster speed and coordination.

PM Modi stressed that there is no substitute to testing, tracking and treatment. Early testing and proper tracking remain key to reduce mortality. He also said that local administrations need to be proactive and sensitive to people's concerns. He directed that close coordination with States must be ensured in handling the pandemic. He said that all necessary measures must be taken to ramp up the availability of hospital beds for Covid patients. The Prime Minister also directed that additional supply of beds through temporary hospitals and isolation centres should be ensured.

PM spoke about the need to utilize the full potential of India's pharmaceutical industry to meet the rising demand of various medicines. He reviewed the status of the supply of Remdesivir and other medicines. The Prime Minister was briefed on actions taken to address the issue of availability of Remdesivir. Through the efforts of the Government, capacity and production augmentation for manufacturing of Remdesivir has been ramped up to provide around 74.10 lakh vials/month in May while the normal production output in January-February being just 27-29 lakh vials/month. Supplies have also increased from 67,900 vials on 11th April going up to over 2,06,000 vials on 15th April 2021 which are being particularly focused on states with high caseload and high demand. He took note of the ramped up production capacity and directed that issues relating to real-time supply chain management to States must be resolved urgently in coordination with the States. The Prime Minister directed that the use of Remdesivir and other medicines must be in accordance with approved medical guidelines and that their misuse and black marketing must be strictly curbed.

ALSO READ: 

On the issue of the supply of medical oxygen, the Prime Minister directed that the installation of approved medical oxygen plants should be sped up. 162 PSA Oxygen plants are being installed in 32 States/UTs from PM CARES. The officers informed that 1 lakh cylinders are being procured & they will be supplied to states soon. The officers briefed the PM that they are in constant supply with 12 high burden states in assessing the current and future requirement of medical oxygen. A supply mapping plan for 12 high burden states till 30th April has also been undertaken. The Prime Minister also said that the supply of oxygen required for the production of medicines and equipment necessary to handle the pandemic should also be ensured.

The Prime Minister also reviewed the status of availability & supply of ventilators. The Prime Minister noted that a real-time monitoring system has been created, and directed that concerned State governments should be sensitized to use the system proactively.

On the issue of vaccination, the Prime Minister directed all officials to make efforts to utilize the entire national capacity, in the public as well as the private sector, to ramp up vaccine production.

He was joined by Cabinet Secretary, Principal Secretary to PM, Union Home Secretary, Union Health Secretary, Pharma Secretary. Dr V K Paul, Niti Aayog was also present.

(PSU Watch– India's Business News centre that places the spotlight on PSUs, Bureaucracy, Defence and Public Policy is now on Telegram & Twitter as well. Join PSU Watch Channel in your Telegram and follow us on Twitter to stay updated)

SJVN Q2 profit remains flat at Rs 439.9 crore

ReNew will install solar power plants in kitchens of Akshaya Patra Foundation

JNPA records nearly 12% rise in Oct container traffic

GAIL reports strong H1 FY'25 financial performance with record highs in EBITDA, PBT, and net profit

NBCC secures Rs 500 crore contract from BIS